New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
3-D printed ankle joints help patients walk again

3-D printed ankle joints help patients walk again

by Georgia Gowing,Macquarie UniversityCredit: Pixabay/CC0 Public DomainIn a world where hip and knee replacements have become common, orthopedic surgeons remain surprisingly divided over ankle r
Arthritis and Rheumatism March 14,2024
3-D printed ankle joints help patients walk again

3-D printed ankle joints help patients walk again

by Georgia Gowing,Macquarie UniversityCredit: Pixabay/CC0 Public DomainIn a world where hip and knee replacements have become common, orthopedic surgeons remain surprisingly divided over ankle r
Arthritis and Rheumatism March 14,2024
Diabetic retinopathy tied to lower vision-related quality of life

Diabetic retinopathy tied to lower vision-related quality of life

by Lori SolomonVision-related quality of life (VRQoL) declines with the presence and higher severity of diabetic retinopathy (DR), according to a review published online Feb. 1 inJAMA Ophthalmol
Diabetes & Endocrinology March 14,2024
Diabetic retinopathy tied to lower vision-related quality of life

Diabetic retinopathy tied to lower vision-related quality of life

by Lori SolomonVision-related quality of life (VRQoL) declines with the presence and higher severity of diabetic retinopathy (DR), according to a review published online Feb. 1 inJAMA Ophthalmol
Diabetes & Endocrinology March 14,2024
High weekly physical activity levels linked to lower kidney disease risk in diabetes and overweight/obesity

High weekly physical activity levels linked to lower kidney disease risk in diabetes and overweight/obesity

by British Medical JournalCredit: CC0 Public DomainClocking up high weekly levels of moderate to vigorous intensity physical activity is linked to a lower risk of developing chronic kidney diseas
Diabetes & Endocrinology March 14,2024
High weekly physical activity levels linked to lower kidney disease risk in diabetes and overweight/obesity

High weekly physical activity levels linked to lower kidney disease risk in diabetes and overweight/obesity

by British Medical JournalCredit: CC0 Public DomainClocking up high weekly levels of moderate to vigorous intensity physical activity is linked to a lower risk of developing chronic kidney diseas
Diabetes & Endocrinology March 14,2024
Blood test could determine diabetes risks

Blood test could determine diabetes risks

by Edith Cowan UniversityCumulative incidence of type 2 diabetes across CumCRP-by-CumMHR strata.G1 CumCRP < 1mg/L & CumMHR < 0.2340; G2 1 ≤ CumCRP < 3mg/L & Cum
Diabetes & Endocrinology March 14,2024
Blood test could determine diabetes risks

Blood test could determine diabetes risks

by Edith Cowan UniversityCumulative incidence of type 2 diabetes across CumCRP-by-CumMHR strata.G1 CumCRP < 1mg/L & CumMHR < 0.2340; G2 1 ≤ CumCRP < 3mg/L & Cum
Diabetes & Endocrinology March 14,2024
Faster walking speed of 4 km+/hour linked to significantly lower type 2 diabetes risk

Faster walking speed of 4 km+/hour linked to significantly lower type 2 diabetes risk

by British Medical JournalCredit: CC0 Public DomainWalking at a speed of 4 or more km an hour is linked to a significantly lower risk of type 2 diabetes, suggests a pooled data analysis of the av
Diabetes & Endocrinology March 14,2024
Faster walking speed of 4 km+/hour linked to significantly lower type 2 diabetes risk

Faster walking speed of 4 km+/hour linked to significantly lower type 2 diabetes risk

by British Medical JournalCredit: CC0 Public DomainWalking at a speed of 4 or more km an hour is linked to a significantly lower risk of type 2 diabetes, suggests a pooled data analysis of the av
Diabetes & Endocrinology March 14,2024
Risk for rheumatoid arthritis reduced for patients with T2DM

Risk for rheumatoid arthritis reduced for patients with T2DM

(HealthDay)—Patients with type 2 diabetes mellitus (T2DM) have a reduced risk for rheumatoid arthritis (RA), which may be due to statin use, according to a study published online Feb. 16 inRheum
Arthritis and Rheumatism March 14,2024
Risk for rheumatoid arthritis reduced for patients with T2DM

Risk for rheumatoid arthritis reduced for patients with T2DM

(HealthDay)—Patients with type 2 diabetes mellitus (T2DM) have a reduced risk for rheumatoid arthritis (RA), which may be due to statin use, according to a study published online Feb. 16 inRheum
Arthritis and Rheumatism March 14,2024
Scientists develop experimental medication that shows promise in treating diabetic macular edema

Scientists develop experimental medication that shows promise in treating diabetic macular edema

by University of MontrealCredit: Unsplash/CC0 Public DomainDiabetes can lead to eye problems, and a common one is diabetic macular edema (DME), causing vision loss.A study published in&nbsp
Diabetes & Endocrinology March 14,2024
Scientists develop experimental medication that shows promise in treating diabetic macular edema

Scientists develop experimental medication that shows promise in treating diabetic macular edema

by University of MontrealCredit: Unsplash/CC0 Public DomainDiabetes can lead to eye problems, and a common one is diabetic macular edema (DME), causing vision loss.A study published in&nbsp
Diabetes & Endocrinology March 14,2024
Humanized mice reveal arsenic may raise diabetes risk only for males

Humanized mice reveal arsenic may raise diabetes risk only for males

by Krishna Ramanujan,Cornell UniversityMeasuring arsenic in liver and adipose tissue of humanized and wild-type mice. (A) Arsenical quantification in isolated liver of mice (WT male, n=5; WT fem
Diabetes & Endocrinology March 14,2024
Humanized mice reveal arsenic may raise diabetes risk only for males

Humanized mice reveal arsenic may raise diabetes risk only for males

by Krishna Ramanujan,Cornell UniversityMeasuring arsenic in liver and adipose tissue of humanized and wild-type mice. (A) Arsenical quantification in isolated liver of mice (WT male, n=5; WT fem
Diabetes & Endocrinology March 14,2024
Researchers pioneer novel stem cell therapy for diabetic wound healing

Researchers pioneer novel stem cell therapy for diabetic wound healing

by TranSpreadHypoxia facilitates exosome production and release from BMSCs. (a) Transmission electron microscopy (TEM) revealed the morphology of noBMSC-Exos and hyBMSC-Exos (scale bar: 100nm).
Diabetes & Endocrinology March 14,2024
Researchers pioneer novel stem cell therapy for diabetic wound healing

Researchers pioneer novel stem cell therapy for diabetic wound healing

by TranSpreadHypoxia facilitates exosome production and release from BMSCs. (a) Transmission electron microscopy (TEM) revealed the morphology of noBMSC-Exos and hyBMSC-Exos (scale bar: 100nm).
Diabetes & Endocrinology March 14,2024
Anifrolumab shows long-term promise in patients with lupus

Anifrolumab shows long-term promise in patients with lupus

by WileyCredit: CC0 Public DomainType I interferon (IFN) is a powerful immune activator that is present at high levels in the majority of patients with lupus, an autoimmune disease. InArthr
Arthritis and Rheumatism March 14,2024
Anifrolumab shows long-term promise in patients with lupus

Anifrolumab shows long-term promise in patients with lupus

by WileyCredit: CC0 Public DomainType I interferon (IFN) is a powerful immune activator that is present at high levels in the majority of patients with lupus, an autoimmune disease. InArthr
Arthritis and Rheumatism March 14,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com